Literature DB >> 15023283

Innovative Surgical Strategies: Minimally Invasive CABG and Off-pump CABG.

Afshin Ehsan1, Prem Shekar, Sary Aranki.   

Abstract

Minimally invasive coronary artery bypass grafting (CABG) and off-pump coronary artery bypass grafting (OPCAB) have made up a significant facet of the recent attempts of surgical myocardial revascularization to evolve. Driven by an effort to limit the deleterious effects of cardiopulmonary bypass (CPB), along with a response to both the growing interests in performing procedures through smaller incisions and the successes of catheter-based therapies, these therapeutic options have found themselves moving into the future by resurrecting their past. Minimally invasive CABG is the procedure by which coronary grafting is performed through a small anterior thoracotomy, without the use of CPB. Although feasible, the inability to offer a more thorough degree of revascularization has limited the applicability of this procedure and, therefore, accounts for its overall minor contribution to the number of coronary revascularizations performed annually. Conversely, as the technical feasibility of performing complete revascularization without CPB has been achieved with OPCAB, its place as a mode of therapy remains uncertain. Several clinical trials have been performed to date with only a few being done in a prospective, randomized fashion. From this data has come a mix of information regarding either improvements or, at a minimum, no change in the rate of complications between CABG with, and without, CPB, while at the same time maintaining equivalent short-term graft patencies. The question remains, however, to which patient population is this approach to CABG optimal? Our practice has largely reserved OPCAB for those patients in whom manipulation of the aorta is considered not feasible due to severe calcification or in "high-risk" patients who are felt to be unable to tolerate the adverse physiologic effects of CPB. This makes up approximately 15% of our CABG population, roughly equal to the national average, with the remaining patients being revascularized with the assistance of CPB.

Entities:  

Year:  2004        PMID: 15023283     DOI: 10.1007/s11936-004-0013-8

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  30 in total

1.  Xpose: a new device that provides reproducible and easy access for multivessel beating heart bypass grafting.

Authors:  M K Dullum; F G Resano
Journal:  Heart Surg Forum       Date:  2000       Impact factor: 0.676

2.  Economic outcome of off-pump coronary artery bypass surgery: a prospective randomized study.

Authors:  R Ascione; C T Lloyd; M J Underwood; A A Lotto; A A Pitsis; G D Angelini
Journal:  Ann Thorac Surg       Date:  1999-12       Impact factor: 4.330

3.  Aortocoronary bypass with saphenous vein graft. Seven-year follow-up.

Authors:  H E Garrett; E W Dennis; M E DeBakey
Journal:  JAMA       Date:  1973-02-12       Impact factor: 56.272

4.  Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique.

Authors:  R G Favaloro
Journal:  Ann Thorac Surg       Date:  1968-04       Impact factor: 4.330

5.  Early outcome after off-pump versus on-pump coronary bypass surgery: results from a randomized study.

Authors:  D van Dijk; A P Nierich; E W Jansen; H M Nathoe; W J Suyker; J C Diephuis; W J van Boven; C Borst; E Buskens; D E Grobbee; E O Robles De Medina; P P de Jaegere
Journal:  Circulation       Date:  2001-10-09       Impact factor: 29.690

6.  The LAST operation is safe and effective: MIDCABG clinical and angiographic evaluation.

Authors:  A Repossini; S Moriggia; V Cianci; O Parodi; P Sganzerla; G Baldrighi; F Bortone; V Arena
Journal:  Ann Thorac Surg       Date:  2000-07       Impact factor: 4.330

7.  Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients.

Authors:  F J Benetti; G Naselli; M Wood; L Geffner
Journal:  Chest       Date:  1991-08       Impact factor: 9.410

8.  Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators.

Authors:  G W Roach; M Kanchuger; C M Mangano; M Newman; N Nussmeier; R Wolman; A Aggarwal; K Marschall; S H Graham; C Ley
Journal:  N Engl J Med       Date:  1996-12-19       Impact factor: 91.245

9.  Stroke after conventional versus minimally invasive coronary artery bypass.

Authors:  Sotiris C Stamou; Kathleen A Jablonski; Albert J Pfister; Peter C Hill; Mercedes K C Dullum; Ammar S Bafi; Steven W Boyce; Kathleen R Petro; Paul J Corso
Journal:  Ann Thorac Surg       Date:  2002-08       Impact factor: 4.330

10.  Safety and cost-effectiveness of MIDCABG in high-risk CABG patients.

Authors:  D F Del Rizzo; W D Boyd; R J Novick; F N McKenzie; N D Desai; A H Menkis
Journal:  Ann Thorac Surg       Date:  1998-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.